Publications and communications of Christophe BONNET

LOVINFOSSE, P., Ferreira, M., WITHOFS, N., JADOUL, A., Derwael, C., Frix, A.-N., GUIOT, J., BERNARD, C., Diep, A. N., Donneau, A.-F., LEJEUNE, M., BONNET, C., Vos, W., Meyer, P., & HUSTINX, R. (2022). Distinction of lymphoma from sarcoidosis at FDG PET/CT - evaluation of radiomic-feature guided machine learning versus human reader performance. Journal of Nuclear Medicine, 121.263598. doi:10.2967/jnumed.121.263598

BONNET, C., Dupuis, J., Tilly, H., Lamy, T., Fruchart, C., le Gouill, S., Thieblemont, C., Morschhauser, F., Casasnovas, O., Bouabdallah, K., Ghesquieres, H., Van Den Neste, E., André, M., Cartron, G., & Salles, G. (30 March 2022). Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group. Cancers, 14, 1761. doi:10.3390/cancers14071761

Jullien, M., Tessoulin, B., Ghesquières, H., Oberic, L., Morschhauser, F., Tilly, H., Ribrag, V., Lamy, T., Thieblemont, C., Villemagne, B., Gressin, R., Bouabdallah, K., Haioun, C., Damaj, G., Fornecker, L.-M., Schiano De Colella, J.-M., Feugier, P., Hermine, O., Cartron, G., ... Le Gouill, S. (07 September 2021). Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years. Cancers, 13, 4503. doi:10.3390/cancers13184503

Buedts, L., Wlodarska, I., Finalet-Ferreiro, J., Gheysens, O., Dehaspe, L., Tousseyn, T., Fornecker, L.-M., Lazarovici, J., Casasnovas, R.-O., Gac, A.-C., BONNET, C., Bouabdallah, K., Copie-Bergman, C., Fabiani, B., Dierickx, D., Marcelis, L., Vermeesch, J., André, M., & Vandenberghe, P. (2021). The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA. Blood Advances, 5, 1991-2002. doi:10.1182/bloodadvances.2020003039

Camus, V., Rossi, C., Sesques, P., Lequesne, J., Tonnelet, D., Haioun, C., Durot, E., Willaume, A., Gauthier, M., Moles-Moreau, M.-P., Antier, C., Lazarovici, J., Monjanel, H., Bernard, S., Tardy, M., Besson, C., Lebras, L., Choquet, S., Le Du, K., ... Tilly, H. (2021). Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study. Blood Advances, 5, 3862-3872. doi:10.1182/bloodadvances.2021004778

Le Gouill, S., Ghesquieres, H., Obéric, L., Morschhauser, F., Tilly, H., Ribrag, V., Lamy, T., Thieblemont, C., Maisonneuve, H. G., Gressin, R., Bouabdallah, K., Haioun, C., Damaj, G., Fornecker, L. M., Bouabdallah, R., Feugier, P., Sibon, D., Cartron, G., BONNET, C., ... Casasnovas, O. (2021). Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA. Blood, 137 (17), 2307-2320. doi:10.1182/blood.2020008750

LEBAS, E., COLLINS, P., BONNET, C., Libon, F., DEZFOULIAN, B., & NIKKELS, A. (2021). Comment je traite… le mycosis fongoïde : à propos du brentuximab védotine, une nouvelle arme thérapeutique. Revue Médicale de Liège, 76 (4), 224-231.

MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481.

Oberic L., Peyrade F., Puyade M., BONNET, C., Dartigues-Cuillères P., Fabiani B., Ruminy P., Maisonneuve H., Abraham J., Thieblemont C., Feugier P., Salles G., Bijou F., Pica GM., Damaj G., Haioun C., Casasnovas RO., Farhat H., Le Calloch R., ... Jardin F. (2021). Subcutaneous Rituximab-MiniCHOP compared with subcutaneous Rituximab-MiniCHOP plus Lenalidomide in diffuse large B-Cell lymphoma for patients age 80 years or older. Journal of Clinical Oncology, 39, 1203-1213. doi:10.1200/JCO.20.02666

RADERMECKER, A., BONNET, C., LUTTERI, L., CHAPELLE, A.-C., PETIGNOT, S., LIEVENS, I., & CAERS, J. (2021). Un cas illustratif de syndrome de POEMS. Revue Médicale de Liège, 76, 156-159.

Houot, R., Cartron, G., Bijou, F., de Guibert, S., Salles, G. A., Fruchart, C., Bouabdallah, K., Maerevoet, M., Feugier, P., Le Gouill, S., Tilly, H., Casasnovas, R.-O., Moluçon-Chabrot, C., Van Den Neste, E., Zachee, P., André, M., Bonnet, C., Haioun, C., Van Hoof, A., ... Morschhauser, F. (2019). Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study. Leukemia, 33, 776-780. doi:10.1038/s41375-018-0282-y

Morschhauser F., Le Gouill S., Feugier P., Bailly S., Nicolas-Virelizier E., Bijou F., Salles GA., Tilly H., Fruchart C., Van Eygen K., Snauwaert S., BONNET, C., Haioun C., Thieblemont C., Bouabdallah R., Wu KL., Canioni D., Meignin V., Cartron G., & Houot R. (2019). Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study. Lancet. Haematology, 6, 429-e437. doi:10.1016/S2352-3026(19)30089-4

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600

Cabannes-Hamy, A., Peyrade, F., Jardin, F., Emile, J., Delwail, V., Mounier, N., Haioun, C., Perrot, A., Fitoussi, O., Lara, D., Delarue, R., André, M., Offner, F., Gherquières, H., Pascal, L., Soussain, C., Lazarovici, J., Schiano, J., Gaulard, P., ... BONNET, C. (Other coll.). (2018). Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies. Cancer Medicine. doi:10.1002/cam4.1139

Fossard, G., Broussais, F., Coelho, I., Bailly, S., Nicolas-Virelizier, E., Toussaint, E., Lancesseur, C., Le Bras, F., WILLEMS, E., Tchernonog, E., Chalopin, T., Delarue, R., Gressin, R., Chauchet, A., Gyan, E., Cartron, G., Bonnet, C., BOUABDALLAH, R., SALLES, G., & BACHY, E. (2018). Role of up-front autologous stem cell transplantation in peripheral T-cell lymphoma for patients in response after induction: An analysis of patients from LYSA centers. Annals of Oncology, 29, 715-723. doi:10.1093/annonc/mdx787

FOSSARD, G., BROUSSAIS, F., COELHO, I., BAILLY, S., NICOLAS-VIRELIZIER, E., TOUSSAINT, E., LANCESSEUR, C., LE COTTEREAU, A., EL-GALALY, T., BECKER, S., PETERSON, L., Bonnet, C., PRIOR, J., TILLY, H., HUTCHINGS, M., CASASNOVAS, O., & MEIGNAN, M. (2018). Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients. European Journal of Nuclear Medicine, 59. doi:10.2967/jnumed.117.193946

Vergote, V., Janssens, A., André, M., Bonnet, C., Van Hende, V., Van Den Neste, E., Van Eygen, K., Maerevoet, M., Pranger, D., Schroyens, W., Debussche, S., Maertens, V., Beel, K., Lemmens, J., Caron, C., Delrieu, V., Van Den Broeck, I., Vanstraelen, G., Jacquy, C., ... Van Hoof, A. (22 February 2017). Results from the Belgian mantle cell lymphoma registry. Acta Clinica Belgica, 38, 1-7. doi:10.1080/17843286.2017.1293328

Bron, D., Aurer, I., Bonnet, C., Caballero, D., Falandry, C., Kimby, E., Soubeyran, P., Zucca, E., Bosly, A., Coiffier, B., & André, M. (2017). Unmet needs in the scientific approach to older patients with lymphoma. Haematologica, 102 (6), 972-975. doi:10.3324/haematol.2017.167619

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845

SID, S., Baron, F., WILLEMS, E., Caers, J., Bonnet, C., DE PRIJCK, B., LEJEUNE, M., HAFRAOUI, K., Servais, S., JASPERS, A., & Beguin, Y. (November 2016). Hematologic recovery after autologus stem cell transplantation in multiple myeloma: a single center experience of 225 patients. Paper presented at 16ème Congrès commun de la SFGM-TC & 8ème de la SFBCT, Liège, Belgium.

Vallois, D., Dobay, M. P. D., Morin, R. D., Lemonnier, F., Missiaglia, E., Juilland, M., Iwaszkiewicz, J., Fataccioli, V., Bisig, B., Roberti, A., Grewal, J., Bruneau, J., Fabiani, B., Martin, A., Bonnet, C., Michielin, O., Jais, J.-P., Figeac, M., Bernard, O. A., ... de Leval, L. (15 September 2016). Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas. Blood, 128, 1490-1502. doi:10.1182/blood-2016-02-698977

WITHOFS, N., COUSIN, F., TANCREDI, T., SIMONI, P., DE PRIJCK, B., HAFRAOUI, K., BONNET, C., HUSTINX, R., BEGUIN, Y., & CAERS, J. (14 June 2016). Comparison of combined whole-body 18F-NAF and 18F-FDG PET/CT versus MRI for the detection of myeloma lesions. Paper presented at SNMMI 2016 Annual Meeting.

Springael, C., Delrieu, V., Wu, K. L., Schroyens, W., Bonnet, C., Bron, D., & Janssens, A. (June 2016). BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias. Belgian Journal of Hematology, 7, 103-111.

Bonnet, C. (May 2016). La prise en charge du lymphome chez le patient âgé. Paper presented at Axis congress center, Mont-St-Guibert, Belgium.

Cottereau, A. S., Becker, S., Broussais, F., Casasnovas, O., Kanoun, S., Roques, M., Charrier, N., Bertrand, S., Delarue, R., Bonnet, C., Hustinx, R., Gaulard, P., de Leval, L., Vera, P., Itti, E., Mounier, N., Haioun, C., Tilly, H., & Meignan, M. (April 2016). Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)†. Annals of Oncology, 27, 719-724. doi:10.1093/annonc/mdw011

Pilorge, S., Harel, S., Ribrag, V., Larousserie, F., Willems, L., Franchi, P., Legoff, M., Biau, D., Anract, P., Roux, C., Blanc-Autran, E., Delarue, R., Gisselbrecht, C., Ketterer, N., Recher, C., Bonnet, C., Peyrade, F., Haioun, C., Tilly, H., ... Tamburini, J. (2016). Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies. Leukemia and Lymphoma, 57, 2820-2826. doi:10.1080/10428194.2016.1177180

BONNET, C., & BOSLY, A. (October 2015). Highlights of the 13th International Conference on Malignant Lymphoma. Belgian Journal of Hematology, 6 (4), 173-178.

VAN HENDE, V., BRON, D., VAN DEN NESTE, E., BONNET, C., ANDRE, M., VAN HOOF, A., DIERICKX, D., VERHOEF, G., TOUSSEYN, T., JANSSENS, A., DE WILDE, V., WU, K. L., & HEIMANN, P. (October 2015). Waldenström's macroglobulinaemia: Belgian Hematology Society guidelines. Belgian Journal of Hematology, 6 (4), 142-151.

JASPERS, A., Baron, F., SERVAIS, S., LEJEUNE, M., WILLEMS, E., SEIDEL, L., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (September 2015). Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival. American Journal of Hematology, 90 (9), 197-199. doi:10.1002/ajh.24100

JASPERS, A., Baron, F., Maertens, J., DE PRIJCK, B., Schots, R., Bonnet, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & Beguin, Y. (July 2015). Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation [letter to the editor]. American Journal of Hematology, 90 (7), 133-4. doi:10.1002/ajh.24013

BONNET, C., Janssens, A., Wu, K., Schroyens, W., Van Hende, V., Heimann, P., Tousseyn, T., André, M., Bron, D., Van Hoof, A., Verhoef, G., DE PRIJCK, B., Beguin, Y., & Dierickx, D. (2015). BHS guidelines for the treatment of Burkitt lymphoma. Belgian Journal of Hematology, 6 (2), 61-69.

Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556.

FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology.

SID, S., Dugauquier, C., DE PRIJCK, B., BONNET, C., & Beguin, Y. (2015). Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 6 (2), 74-78.

JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948.

MOERMANS, C., BONNET, C., WILLEMS, E., Baron, F., NGUYEN DANG, D., HENKET, M., Sele, J., CORHAY, J.-L., Beguin, Y., & Louis, R. (November 2014). Sputum cytokines levels in patients undergoing hematopoietic SCT (HSCT) and comparison with healthy subjects and COPD: a pilot study. Bone Marrow Transplantation, 49 (11), 1382-1388. doi:10.1038/bmt.2014.164

MOURIN, E., VAN HOOF, A., BOSLY, A., Bonnet, C., DE WILDE, V., DOYEN, C., HERMANS, C., JANSSENS, A., MICHAUX, L., SCHROYENS, W., SONET, A., VAN DEN NESTE, E., VERHOEF, G., ZACHEE, P., & ANDRE, M. (September 2014). Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society. Belgian Journal of Hematology, 5, 89.

BRON, D., VAN DEN NESTE, E., KENTOS, A., OFFNER, F., SCHROYENS, W., Bonnet, C., VAN HOOF, A., VERHOEF, G., & JANSSENS, A. (March 2014). BHS guidelines for the treatment of marginal zone lymphomas. Belgian Journal of Hematology, 5, 12-17.

André, M., DE PRIJCK, B., Kentos, A., Van Hoof, A., Bonnet, C., Sonet, A., Maerevoet, M., Van Den Neste, E., Bosly, A., & Mounier, N. (2014). ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial. Belgian Journal of Hematology, 12.

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (2014). Long-term survival in patients receiving rhEPO following allogeneic hematopoietic cell transplantation. Belgian Journal of Hematology, 14.

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2014). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomized trial. Blood, 124, 33-41. doi:10.1182/blood-2014-01-546333

SID, S., Dugauquier, D., DE PRIJCK, B., Bonnet, C., & Beguin, Y. (2014). Hemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 17-18.

SOMJA, J., Bisig, B., de Leval, L., Bonnet, C., HERENS, C., & Siebert, R. (2014). Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly. Virchows Archiv. doi:10.1007/s00428-014-1560-3

Bonnet, C., MENTEN, C., LAMBERT, F., Gothot, A., Baron, F., CAERS, J., HERENS, C., & Beguin, Y. (25 January 2013). Simultaneous diagnosis of CLL and CML in a single patient with evidence for two different cell clones. Poster session presented at BHS, General Annual Meeting.

BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552

Bisig, B., de Reyniès, A., Bonnet, C., Sujobert, P., Rickman, D. S., Marafioti, T., Delsol, G., Lamant, L., Gaulard, P., & de Leval, L. (2013). CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. Haematologica, 98/n°8, 1250-1258. doi:10.3324/haematol.2012.081935

Bossard, C., Dobay, M. P., Lamant, L., Missiglia, E., Parrens, M., Martin, A., Tournillac, O., Haioun, C., Bonnet, C., Berger, F., Bouchind'homme, B., Delarue, R., Rousset, T., Thiebault, S., Picquenot, J., Fabiani, B., Delorenzi, M., Gaulard, P., & de Leval, L. (2013). Correlation between RNA and protein levels in a large european series from the LYSA. Hematological Oncology, 31 Suppl.1, 146-147.

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2013). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomised trial. Belgian Journal of Hematology, 16.

Ketterer, N., Coiffier, B. B., Thieblemont, C., Fermé, C., Brière, J. F., Casasnovas, O., Bologna, S., Christian, B., Connerotte, T., Récher, C., Bordessoule, D., Fruchart, C., Delarue, R., Bonnet, C., Morschhauser, F. A., Anglaret, B., Soussain, C., Fabiani, B., Tilly, H., & Haioun, C. (2013). Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B). Annals of Oncology, 24/n°4, 1032-1037. doi:10.1093/annonc/mds600

Moermans, C., Poulet, C., HENKET, M., Bonnet, C., WILLEMS, E., Baron, F., Beguin, Y., & Louis, R. (2013). Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respiratory Medicine, 107, 2071-2080. doi:10.1016/j.rmed.2013.10.013

Van Obbergh, F., Van Hoof, A., Verhoef, G., Dierickx, D., De Wilde, V., Offner, F., Bron, D., Sonet, A., André, M., Janssens, A., Bonnet, C., DE PRIJCK, B., Zachée, P., Kentos, A., Schroyens, W., & Van Den Neste, E. (2013). Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS). Belgian Journal of Hematology, 4 (3), 90-101.

Verhoef, G., Schroyens, W., Bron, D., Bonnet, C., De Wilde, V., Van Hoof, A., Janssens, A., Dierickx, D., André, M., & Van Den Neste, E. (2013). Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL. Belgian Journal of Hematology, 4 (2), 51-57.

Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90.

de Leval, L., BONNET, C., Copie-Bergman, C., SEIDEL, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. Annals of Oncology. doi:10.1093/annonc/mds150

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T. J., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinc clinicopathologic features: a GELA study. Annals of Oncology, 23(12), 3143-3151.

Debussche, S., Van Hoof, A., Sonet, A., Bonnet, C., Janssens, A., Verhoef, G., Dierickx, D., De Wilde, V., Bron, D., Schroyens, W., Van Den Neste, E., & Offner, F. (2012). Guidelines of the Belgian Hematological Society for newly diagnosed and relapsed follicular lymphoma 2012. Belgian Journal of Hematology, 3 (2), 41-50.

Bonnet, C., CAERS, J., DE PRIJCK, B., HAFRAOUI, K., & Beguin, Y. (2011). Lymphome du manteau : prise en charge 2011. Revue Médicale Suisse, 7, 1644-1649.

CAERS, J., BONNET, C., GRAUX, C., DE PRIJCK, B., & BEGUIN, Y. (2011). Prise en charge actuelle des syndromes myélodysplasiques. Revue Médicale Suisse, 7, 1634-1643.

Récher, C., Coiffier, B., Haioun, C., Molina, T. J., Fermé, C., Casasnovas, O., Thièblement, C., Bosly, A., Laurent, G., Morschhauser, F., Ghesquières, H., Jardin, F., Bologna, S., Fruchart, C., Corront, B., Gabarre, J., Bonnet, C., Janvier, M., Canioni, D., ... Tilly, H. (2011). Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. Lancet, 378(9806), 1858-1867. doi:10.1016/S0140-6736(11)61040-4

Bosly, A., Delarue, R., Bonnet, C., Van Hoof, A., Van Den Neste, E., Maerevoel, M., Zachée, P., Bron, D., Mathieux, V., Fournier, M., Molina, T., Haioun, C., & Tilly, H. (2010). R-CHOP14 compared to R-CHOP21 in elderly patients with diffuse large B-ell lymphoma: results of the interim analysis of the LNH03- GELA study. Poster session presented at 25th General Meeting of the Belgian Hematological Society.

Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176.

Beguin, Y., Maertens, J., DE PRIJCK, B., Schots, R., Frère, P., Bonnet, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., LEJEUNE, M., SERVAIS, S., THeunissen, K., Fillet, G., & Baron, F. (2009). A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation. Poster session presented at 24th General Meeting of the Belgian Hematological Society, Oostende, Belgium.

Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7.

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248
* These authors have contributed equally to this work.

de Leval, L., Bonnet, C., Brière, J., Molina, T., Petrella, T., Bosq, J., Falini, B., Gisselbrecht, C., Reyes, F., Fillet, G., & Gaulard, P. (2008). Diffuse large B-cell lymphoma (DLBCL) of the waldeyer'ring (WR) frequently have a GC-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annals of Oncology, 13(suppl 4), 366.

Bonnet, C. (2007). Contribution à l'étude des lymphomes: Aspects pronostiques et thérapeutiques. Unpublished doctoral thesis, ULiège - Université de Liège.
Jury: .

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T. J., Thieblemont, C., Ferme, C., Quesnel, B., Brassiene, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (01 March 2007). CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de I'Adulte. Journal of Clinical Oncology, 25 (7), 787-792. doi:10.1200/JCO.2006.07.0722

Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x

Bonnet, C., & Fillet, G. (2007). How can we determine the role of radiotherapy in the treatment of localized aggressive non Hodgkin's lymphoma? Journal of Clinical Oncology, 25/n°19, 2857-2858.

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Falini, B., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse large B-cell lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annual Meeting Abstracts, 110, 1561.

de Leval, L., Bonnet, C., Copie-Bergmann, C., Seidel, L., Brière, J., Molina, T., Fabiani, B., Brunangelo, F., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse Large B-cell Lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Blood.

De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90.

Trimeche, M., Bonnet, C., Korbi, S., Boniver, J., & de Leval, L. (2007). Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study. Leukemia and Lymphoma, 48 (7), 1323-1331. doi:10.1080/10428190701411177

Bonnet, C., Beguin, Y., FASSOTTE, M.-F., & Fillet, G. (2006). Limited usefulness of CA 125 measurement in the management of hodgkin's and non-hodgkin's lymphomas. Poster session presented at 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (January 2006). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressie lymphoma: final results of the LNH 93-4 GELA Study. Poster session presented at 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Ferme, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2006). No role for chemoradiotherapy compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study. Poster session presented at 21st General Meeting of the Belgian Hematological Society.

Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255

Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2006). Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial. Paper presented at 21st General Meeting of the Belgian Hematological Society.

Fillet, G., Bonnet, C., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2005). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study. Blood, 106 (15).

Fillet, G., Bonnet, C., Mounier, N., Ganem, N., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes. (2005). No advantage of chemoradiotherapy over chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: results of the LNH93-4 GELA study. Annals of Oncology, 16 (suppl 5).

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075).

Gillain, S., Gennigens, C., Sautois, B., Polus, M., Bonnet, C., Fillet, G., & Jerusalem, G. (2004). Traitement du cancer du sein chez la personne âgée. Revue Médicale Suisse, 62, 1618-21.

Bonnet, C., Fillet, G., Bosly, A., Van Hoof, A., Offner, F., Van Den Neste, E., DE PRIJCK, B., Deflandre, A., Gisselbrecht, C., & Reyes, F. (2003). Radiotherapy is unnecessary in elderly patients with localized aggressive non hodgkin's lymphoma: results of the LNH 93-4 study. Paper presented at 18th General Meeting of the Belgian Hematological Society, Brussels, Belgium.

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Annals of Oncology, 13 (suppl 2), 27.

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A. M., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Blood, 100 (11), 92.

Bonnet, C., Jerusalem, G., Bours, V., & Fillet, G. (2000). Approches thérapeutiques du cancer ovarien. Médecine et Hygiène, 58, 1625-1628.

Malgrange, B., Rogister, B., LEFEBVRE, P., Mazy-Servais, C., Welcher, A. A., Bonnet, C., Hsu, R. Y., Rigo, J.-M., Van De Water, T. R., & Moonen, G. (August 1998). Expression of Growth Factors and Their Receptors in the Postnatal Rat Cochlea. Neurochemical Research, 23 (8), 1133-8. doi:10.1023/A:1020724506337

Malgrange, B., LEFEBVRE, P., van de Water, T. R., Bonnet, C., Monville, F., Rigo, J.-M., Staecker, H., & Moonen, G. (1998). In vitro ototoxicity of aminoglycosides and platin derivatives. A semi-automatic assay for sensory hair cell damage in explanted rat organ of corti. Toxicology in Vitro, 12 (6), 705-714. doi:10.1016/S0887-2333(98)00048-4

Malgrange, B., LEFEBVRE, P., Rigo, J. M., Rogister, B., BELACHEW, S., Coucke, P., Bonnet, C., Van De Water, T. R., & Moonen, G. (1997). Effect of neuropeptides on cultured postnatal auditory neurons. Paper presented at 34th Workshop on Inner Ear Biology.

Malgrange, B., LEFEBVRE, P., Rogister, B., Mazy-Servais, C., Bonnet, C., Van De Water, T. R., & Moonen, G. (1997). Expression of growth factors and their receptors in various compartments of the postnatal cochlea. Paper presented at 10th Meeting ARO.

Rogister, B., Mazy-Servais, C., Leprince, P., Schils, F., Bonnet, C., & Moonen, G. (1996). Molecular cloning of mouse AstaC, a brain protein which is upregulated during development. Paper presented at 1st annual Meeting on Belgian Society for Neuroscience.